J and D talk to Codi Peterson, owner of PharmD Approved, about the Endocannabinoid System (ECS) — the physiological system in our bodies that responds to cannabis. He shares what products are available to pediatric patients suffering from seizures and cancer. Codi also gets D to make a big confession and crushes the myth about cannabis and our memory.

Our guest reviewer, G, tells listeners about the surprising efficacy of the CBD product he consumes in order to alleviate the pain of Crohn’s disease.

Vocabudulary lesson:

  • Endocannabinoid system, aka ECS (n.): the complex cell-signaling system identified in the early 1990s by researchers exploring THC, a well-known cannabinoid.
  • Epidiolex (n.): the first FDA‑approved prescription cannabidiol used to treat seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in patients 1 year of age and older.
  • Marinol (n.): a man-made form of cannabis used to treat patients suffering from loss of appetite, nausea and vomiting due to cancer and chemotherapy.
  • Transmucosal (adj.): supplying a medication through or across a mucous membrane (as of the mouth).

For other sources to listen to this podcast please go to buzzsprout.com.

Codi Peterson

Dr. Codi Peterson is a clinical Pediatric Pharmacist pursuing a MS in Medical Cannabis Science & Therapeutics from University of Maryland, School of Pharmacy. With this degree he wishes improve patient outcomes and quality of life. In addition Codi works with businesses to optimize processes, ensure compliance, and enhance business outcomes.

Codi is most interested in promoting the medicinal value of cannabis, enhancing endocannabinoid health, and driving the industry forward with an evidence based, integrative approach to cannabinoid-focused care.

Leave A Comment